AL-1567

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameAL-1567
Drug Alias NameAL-1567
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action +[1N/A
TargetsAldose reductase
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlcon Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlcon Laboratories Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A